About C-Bridge Capital
C-Bridge Capital is a healthcare dedicated private equity firm, focused on growth and late stage investment opportunities with US$800 million of Assets Under Management. C-Bridge Capital’s current portfolio includes China’s leading players in pharmaceuticals, medical devices, diagnostics and healthcare services.
C-Bridge Capital is committed to support commercialization of cutting edge technologies and companies that fulfil unmet medical needs, thus continuously improving the standard and quality of care for patients.
State of Ownership
Business Development Executive, Nature Publishing Group